Professor Division of Hematology/Oncology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine

Speciality Interests

Pancreatic cancer, Biliary tract cancer

Schedule

schedule of week
05 MON
13
TUE
14
WEN
15
THU
16
FRI
17
AM available available
PM available

Medical School

1996~2001 Ph.D. in Medicine Yonsei University Graduate School of Medical Science, Seoul, Korea 1993~1995 Master in Medicine Yonsei University Graduate School of Medical Science, Seoul, Korea 1985~1991 MD Yonsei University College of Medicine, Seoul, Korea

Specialty Training

Specialty Training
Fellowship   2001~2002 Clinical Fellowship Samsung Medical Center, Sungkyunkwan University School of Medicine
1999~2001 Clinical & Research Fellowship Yonsei Cancer Center, Yonsei Univ. Medical College
Residency   1992~1996 Yonsei Severance Hospital, Yonsei Univ. Medical College, Seoul, Korea
Internship   1991~1992 Yonsei Severance Hospital, Yonsei Univ. Medical College, Seoul, Korea

Other Education

  • 2019~Present Director Director, Precision Medicine Research Center, Samsung Research Institute for Future Medicine, Seoul, Korea
    2015~2021 Director Center for Rare Cancers, Samsung Comprehensive Cancer Center, Seoul, Korea
    2013~Present Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    2007~2013 Associate Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    2006~2008 Postdoc. Fellowhsip Dana-Farber Cancer Inst. /Harvard Medical School, Boston, MA
    2003~2007 Assistant Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    2002~2003 Clinical Assistant Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Participation in Academic Societies
and Research

  • 2022~Present Active member European Society of Medical Oncology (ESMO)
    1999~Present Active member American Society of Clinical Oncology (ASCO)
    2002~Present Active member American Association of Cancer Research (AACR)
    2005~Present Active member Korean Society of Medical Oncology (KSMO)
    2001~Present Active member Korean Cancer Study Group (KCSG)
    1995~Present Active member Korean Cancer Association
    1992~Present Active member Korean Association of Internal Medicine

Thesis

J HEPATO-BIL-PAN SCI 2021 10.1002/jhbp.986

Multi-biomarker panel prediction model for diagnosis of pancreatic cancer

Lee1, DH; Yoon, W; Lee, A; Han, Y; Byun, Y; Kang, JS; Kim, H; Kwon, W; Suh, YA; Choi, Y; Namkung, J; Han, S; Yi, SG; Heo, JS; Han, IW; Park, JO; Park, JK; Kim, SC; Jun, E; Kang, CM; Lee, WJ; Lee, HK; Lee, H; Lee, S; Jeong, SY; Lee, KE; Han, W; Park, T; Jang, JY

J CLIN ONCOL 2021 10.1200/JCO.20.02232

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

Hecht1, JR; Lonardi, S; Bendell, J; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Wang, H; Hozak, RR; Gueorguieva, I; Lin, Y; Rao, S; Ryoo, BY

ESMO OPEN 2021 10.1016/j.esmoop.2021.100049

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)

Park1, HS; Kang, B; Chon, HJ; Im, HS; Lee, CK; Kim, I; Kang, MJ; Hwang, JE; Bae, WK; Cheon, J; Park, JO; Hong, JY; Kang, JH; Kim, JH; Lim, SH; Kim, JW; Kim, JW; Yoo, C; Choi, HJ

CANCERS 2021 10.3390/cancers13071647

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review

Yoo1, C; Shin, SH; Park, JO; Kim, KP; Jeong, JH; Ryoo, BY; Lee, W; Song, KB; Hwang, DW; Park, JH; Lee, JH

ANN SURG TREAT RES 2021 10.4174/astr.2021.100.3.144

Diagnostic model for pancreatic cancer using a multi-biomarker panel

Choi1, YJ; Yoon, W; Lee, A; Han, Y; Byun, Y; Kang, JS; Kim, H; Kwon, W; Suh, YA; Kim, Y; Lee, S; Namkung, J; Han, S; Choi, Y; Heo, JS; Park, JO; Park, JK; Kim, SC; Kang, CM; Lee, WJ; Park, T; Jang, JY

CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

2. Right to be informed and to make an autonomous decision

Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

3. Right to confidentiality

Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

4. Right to request consultation and mediation

In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

5. Right to have values and beliefs respected

Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

6. Right to receive care in a safe setting

Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

Patients' Responsibilities

1. Responsibility to trust and respect the medical team

Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

2. Responsibility to not use dishonest methods for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

3. Responsibility to abide by all hospital regulations

Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.